About Vgenomics
Vgenomics is a company based in Noida (India) founded in 2021 by Rahila Sardar, Sameer Malik, and Preeti Gupta Lal. The company has 1 employees. Vgenomics offers products and services including Genomic Sequencing, Comprehensive Blood Test, and Therapeutics Tools. Vgenomics operates in a competitive market with competitors including Omniome, Novogene Corporation, Baebies, HitGen and Singular Genomics, among others.
- Headquarter Noida, India
- Employees 1
- Founders Rahila Sardar, Sameer Malik, Preeti Gupta Lal
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website vgenomics.in
- Social LinkedIn Facebook Instagram YouTube
- Legal Name Vgenomics India Private Limited
- Date of Incorporation 21 Apr, 2022
- Jurisdiction Delhi, India
- Annual Revenue₹0.15 Cr
FY 2024 · -20% YoY
- Net Loss-₹0.58 Cr
FY 2024 · -383% margin
- EBITDA-₹0.57 Cr
FY 2024 · -378% margin
- InvestorsMumbai Angels
& 3 more
- Employee Count1
Associated legal entities of Vgenomics
Vgenomics operates through Vgenomics India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vgenomics India Private Limited CIN U85300DL2022PTC397081 | Active | 21 Apr 2022 | Delhi, Delhi | ₹0.2 Cr | – | 2 | View details |
Products & Services of Vgenomics
Vgenomics offers a comprehensive portfolio of products and services, including Genomic Sequencing, Comprehensive Blood Test, and Therapeutics Tools.
Service for analyzing genetic data to diagnose rare diseases.
Test panel for screening over 100 rare diseases in newborns.
Proprietary tools to speed up development of treatments for rare diseases.
Funding Insights of Vgenomics
- Total Rounds 1
- Investors Count 4
All 1 funding rounds of Vgenomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2024 | – | Seed | $4.29M | Mumbai Angels, O2 Angels Network |
| Date | Valuation | Stage |
|---|---|---|
| Jan 2024 | $4.29M | •••••••• |
Last known valuation $4.29M (Jan 2024). 4 investors in total: 2 institutional and 2 angel.
Investors in Vgenomics
Vgenomics has secured backing from 4 investors, including venture fund and angel investors. Prominent investors backing the company include Mumbai Angels, O2 Angels Network and Rohit Chanana.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage venture investments are facilitated by Mumbai Angels network. | 2006 | mumbaiangels.com | Mumbai, India | |
Angel network focused on multiple sectors | 2021 | o2angels.net | Delhi, India | |
RC Rohit Chanana | Angel investor, ex-SVP at Hero MotoCorp, focused on startups | – | unknown_7d51f5e9f2444280b | - |
SK Sabine Kapasi | Co-founder of Univalu, angel investor, focused on healthtech and sustainability | – | unknown_41aff6d84bd141a1b | - |
Investor details for Vgenomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Vgenomics India Private Limited (Vgenomics)
Vgenomics India Private Limited is the primary company behind Vgenomics. The board of Vgenomics India Private Limited currently have 2 directors; the longest-serving is Rahila Sardar, appointed in 2022. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rahila Sardar DIN 09580961 | Managing Director | 21 Apr 2022 | 4 yrs 5 mo | Vgenomics India Private Limited |
| Preeti Gupta Lal DIN 09704299 | Director | 14 Aug 2022 | 4 yrs 1 mo | Vgenomics India Private Limited |
People of Vgenomics
3 people are tracked at Vgenomics (3 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
| Co-Founder & CEO | Leadership | |
Sameer Malik | Co-Founder & CBO | Leadership |
| Co-Founder & CSO | Leadership |
Complete people profiles for Vgenomics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Vgenomics
Figures of Vgenomics India Private Limited, the primary company behind Vgenomics, for FY 2024. Revenue was ₹0.15 Cr (-20% year on year). Net loss was -₹0.58 Cr (-383% margin). EBITDA was -₹0.57 Cr (-378% margin).
- ₹0.15 CrRevenue · FY 2024 · -20% YoY
- -₹0.58 CrNet loss · -383% margin
- -₹0.57 CrEBITDA · -378% margin
- ₹0.06 CrPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Vgenomics India Private Limited are on its company page.
Detailed financial statements for Vgenomics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Vgenomics
3 dated milestones of Vgenomics across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Vgenomics is founded.
- Funding First funding round.
- Milestone Reaches Minicorn status.
Competitors of Vgenomics
Vgenomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, Novogene Corporation, Baebies, HitGen and Singular Genomics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. | |
| novogene.com | 2011 | Beijing, China | $75M | 141 | Genomic services and solutions with NGS expertise are provided. | |
| baebies.com | 2013 | Durham, United States | $95.89M | 133 | Provider of diagnostic products for pediatrics | |
| hitgen.com | 2012 | Lanzhou, China | $39.11M | – | DNA-encoded libraries are developed for drug discovery applications. | |
| singulargenomics.com | 2016 | San Diego, United States | – | 169 | Next-generation gene sequencing and multi-omics technologies are provided. | |
| macrogen.com | 1997 | Seoul, South Korea | – | – | Next-generation sequencing and genomics services are provided globally. | |
| blueprintgenetics.com | 2012 | Espoo, Finland | $19.86M | – | Genetic diagnostics and clinical interpretation for hereditary diseases are provided. | |
| 3billion.io | 2016 | Seoul, South Korea | $25.69M | – | AI-driven diagnostic platform for rare genetic diseases is offered. | |
| mgrc.com.my | 2004 | Kuala Lumpur, Malaysia | – | – | Genome sequencing, analysis, and genetic screening services are provided. | |
| genewiz.com | 1999 | South Plainfield, United States | – | 452 | Genomic services are provided for the life sciences industry. |
Detailed competitors of Vgenomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vgenomics
Complete news archive for Vgenomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Vgenomics
10 companies that operate in the same segment as Vgenomics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vgenomics
Vgenomics was founded in 2021 and raised its 1st funding round 3 years after it was founded.
Vgenomics is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.
Rahila Sardar is the current CEO of Vgenomics. They have also founded this company.
Vgenomics has 1 employees.
The primary company behind Vgenomics, Vgenomics India Private Limited, reported revenue of ₹0.15 Cr for FY 2024, down 20% year on year.
Vgenomics was founded in 2021 and is based in Noida, India, where diagnostic and therapeutic solutions for inborn diseases are developed. A comprehensive blood test is offered alongside therapeutic options for rare inborn conditions. Precise whole exome sequencing, RNAseq, and bioinformatics analysis services are also provided to support research and clinical applications in the genomics sector.
Vgenomics's top competitors include Novogene Corporation, Baebies and Singular Genomics.
Vgenomics offers Genomic Sequencing, Comprehensive Blood Test, and Therapeutics Tools.
Vgenomics has 4 investors. Key investors include Mumbai Angels, O2 Angels Network, Rohit Chanana, and Sabine Kapasi.
The valuation of Vgenomics is $4.29M as of Jan 2024.
Vgenomics operates through Vgenomics India Private Limited.
The legal entities of Vgenomics currently have 2 directors, including Rahila Sardar, Preeti Gupta Lal.